COMP <GO>
ALHC vs JNJ // REVENUE GROWTH (YOY)
Alignment Healthcare Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ALHC 2
— JNJ 8
▲ REVENUE GROWTH (YOY) LEADER: ALHC
LAST: $8.06 (-1.47%) • MKT CAP: $1.67B
revenue-growth
46.10%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
revenue-growth
6.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALHC VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALHC | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.90% | 25.50% | -11.60 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.8x | 18.5x | +19.30 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 6.77% | 2.97% | +3.80 | ALHC | /fcf-yield <GO> |
| Operating Margin | 0.40% | 34.70% | -34.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 28.50% | -28.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 46.10% | 6.00% | +40.10 | ALHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.00 | 5.59 | -1.59 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.6 | 62.1 | -30.47 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.67B | $662.49B | -$660.82B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALHC REV | JNJ REV | ALHC GROSS % | JNJ GROSS % | ALHC FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.95B | $94.19B | — | 67.9% | $113.1M | $19.70B |
| FY 2024 | $2.70B | $88.82B | — | 69.1% | -$6.6M | $19.84B |
| FY 2023 | $1.80B | $85.16B | — | — | -$59.2M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALHC // BETA —
JNJ // BETA 1.08